Next Article in Journal
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial
Next Article in Special Issue
Liposomal Forms of Fluoroquinolones and Antifibrotics Decorated with Mannosylated Chitosan for Inhalation Drug Delivery
Previous Article in Journal
Combination of a Chaperone Synthesis Inducer and an Inhibitor of GAPDH Aggregation for Rehabilitation after Traumatic Brain Injury: A Pilot Study
Previous Article in Special Issue
Oxime Therapy for Brain AChE Reactivation and Neuroprotection after Organophosphate Poisoning
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(1), 8; https://doi.org/10.3390/pharmaceutics15010008
Action Date Notes Link
article pdf uploaded. 20 December 2022 15:11 CET Version of Record https://www.mdpi.com/1999-4923/15/1/8/pdf-vor
article supplementary file uploaded. 20 December 2022 15:11 CET - https://www.mdpi.com/1999-4923/15/1/8#supplementary
article pdf uploaded. 21 December 2022 02:30 CET Updated version of record https://www.mdpi.com/1999-4923/15/1/8/pdf-vor
article xml file uploaded 29 December 2022 08:42 CET Original file -
article xml uploaded. 29 December 2022 08:42 CET Update -
article pdf uploaded. 29 December 2022 08:42 CET Updated version of record https://www.mdpi.com/1999-4923/15/1/8/pdf-vor
article html file updated 29 December 2022 08:43 CET Original file -
article xml file uploaded 29 December 2022 09:46 CET Update -
article xml uploaded. 29 December 2022 09:46 CET Update https://www.mdpi.com/1999-4923/15/1/8/xml
article pdf uploaded. 29 December 2022 09:46 CET Updated version of record https://www.mdpi.com/1999-4923/15/1/8/pdf
article html file updated 29 December 2022 09:48 CET Update -
article html file updated 4 March 2023 23:07 CET Update https://www.mdpi.com/1999-4923/15/1/8/html
Back to TopTop